aspsirna0170 details

''''
ASPsiRNA information siRNA Id:aspsirna0170
siRNA Name: shAPPsw
Mismatch information Wild siRNA (As strand 3'->5'):ACUUCACUUCUACCUACGUC
ASP-siRNA (As strand 3'->5'):ACUUCACUUAGACCUACGUC
Mismatch position in siRNA: G10C,A11U
Gene Information Gene Name Amyloid beta (A4) precursor protein(APP)
Target Sequence (5'->3'):TCTCTGAAGTGAAGATGGATGCAGAATTCCGAC
Wild allele (5'->3'):UGAAGUGAAGAUGGAUGCAG
Mutant allele (5'->3'):UGAAGUGAAUCUGGAUGCAG
Position of siRNA on target gene: 2201-2220
Respective Gene/Protein Resources GenBank Accession:NM_000484.3
Cytogenic location:21q21.3
Chromosomal coordinates:21:27,252,860-27,543,445
UniProt ID:P56817
HUGO ID:620
Reference SNp(RefSNP): rs28186516
Disease/Mutation information Target Mutation: c.2010_2011delGAinsTC (p.Lys670_Met671delinsAsnLeu)
Matation type/variant: Indel/missense variant
Mutation at gene level: NG_007376.1:g.278194_278195delGAinsTC
Pathogenic status of mutation: Disease causing
Disease:Alzheimers disease
Clinical Resources ClinVar ID:18093
KEGG disease ID:H00056
OMIM ID: 104300
COSMIC: APP
DECIPHER: APP
GeneTests: APP
ASP siRNA details Mutant allele (5'->3'): UGAAGUGAAUCUGGAUGCAG
ASP-siRNA (As strand 3'->5'):ACUUCACUUAGACCUACGUC
Percentage efficacy of ASP-siRNA for mutant allele:60
Wild allele (5'->3'): UGAAGUGAAGAUGGAUGCAG
ASP-siRNA (As strand 3'->5'):ACUUCACUUAGACCUACGUC
Percentage efficacy of ASP-siRNA for wild allele:10
Relative difference:50
Wild siRNA details Wild allele (5'->3'): UGAAGUGAAGAUGGAUGCAG
Wild siRNA (As strand 3'->5'):ACUUCACUUCUACCUACGUC
Percentage efficacy of wild siRNA for wild allele:68
Wild allele (5'->3'): UGAAGUGAAGAUGGAUGCAG
ASP-siRNA (As strand 3'->5'):ACUUCACUUAGACCUACGUC
Percentage efficacy of Wild sirna for mutant allele:2
Relative difference :66
General information Mismatch incorporated in siRNA/Target:siRNA
Cell-line used: Transgenic mouse model
Experimental technique used: allele-specific qPCR
Transfection method: Lipofectamine Plus(invitrogen)
siRNA expression method: Invitrogen
Post-transfection duration: 48 hours
Concentration used:0.01–6.25nM
Reference:19532137
Delivery method:Adenovirus associated shRNA delivery
Article title:Allele-specific RNAi mitigates phenotypic progression in a transgenic model of Alzheimer's disease.
Authors:Rodríguez-Lebrón E, Gouvion CM, Moore SA, Davidson BL, Paulson HL.
Journal Reference:Mol Ther. 2009 Sep;17(9):1563-73. doi: 10.1038/mt.2009.123. Epub 2009 Jun 16.